Revenio Group Oyj (HLSE:REG1V) is looking for M&A opportunities. Robin Pulkkinen, Chief Financial Officer said, "We still continued in searching for the potential M&A opportunities, especially -- and partnerships, especially to expand the ophthalmic diagnostic device market reach and portfolio. We're in a good financial position, and the operating model is really robust, has really served us well and is geared for value creation also in the future".
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.17 EUR | +0.18% |
|
+3.37% | +3.83% |
Apr. 25 | Transcript : Revenio Group Oyj, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Revenio Group Oyj Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.83% | 810M | |
-30.34% | 15.68B | |
-58.81% | 2.03B | |
+13.47% | 1.79B | |
-21.75% | 1.3B | |
+25.36% | 1.27B | |
-37.72% | 715M | |
-38.88% | 697M | |
+22.88% | 588M | |
-30.29% | 584M |
- Stock Market
- Equities
- REG1V Stock
- News Revenio Group Oyj
- Revenio Group Seeks M&A Opportunities